Healthcare
Healthcare
DST Releases Information on Health & Risk Communication Programme Focusing on COVID-19
Delhi Hospitals to be Reserved for Delhi's Patients: Arvind Kejriwal
Sun Pharma Gets DGCI's Approval for Nafamostat Mesilate Clinical Trials on COVID-19 Patients
Grafdoer Recommences Production with a Brand-New Line of Hygienic Touch-Less Products
Glenmark: Antiviral Favipiravir To Enter into Phase 3 of Clinical Trials